Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)

NCT03559374 is registered in ClinicalTrials.gov with PerkinElmer, Wallac Oy as lead sponsor.

NCT NCT03559374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)
Lead sponsor
PerkinElmer, Wallac Oy
Phase
Observational
Overall status
Unknown status
Start date
June 20, 2018
Completion date
August 31, 2020
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trisomy 13, trisomy 18, trisomy 21